CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 40 filers reported holding CASI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $124,000 | +785.7% | 152,713 | +754.0% | 0.00% | – |
| Q4 2021 | $14,000 | -60.0% | 17,882 | -39.2% | 0.00% | – |
| Q3 2021 | $35,000 | -45.3% | 29,423 | +14.7% | 0.00% | – |
| Q2 2020 | $64,000 | -44.3% | 25,656 | -54.3% | 0.00% | – |
| Q1 2020 | $115,000 | -54.9% | 56,130 | -32.0% | 0.00% | – |
| Q4 2019 | $255,000 | +180.2% | 82,525 | +266.3% | 0.00% | – |
| Q4 2018 | $91,000 | +8.3% | 22,528 | +12.1% | 0.00% | – |
| Q1 2018 | $84,000 | +40.0% | 20,097 | +9.2% | 0.00% | – |
| Q4 2017 | $60,000 | +172.7% | 18,398 | -11.2% | 0.00% | – |
| Q2 2017 | $22,000 | +10.0% | 20,713 | +16.0% | 0.00% | – |
| Q3 2016 | $20,000 | +11.1% | 17,859 | +4.5% | 0.00% | – |
| Q1 2016 | $18,000 | -5.3% | 17,087 | -13.3% | 0.00% | – |
| Q4 2015 | $19,000 | +18.8% | 19,712 | +86.8% | 0.00% | – |
| Q1 2015 | $16,000 | +6.7% | 10,550 | -4.8% | 0.00% | – |
| Q4 2014 | $15,000 | – | 11,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |